Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

$7.5 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying

Published 11/08/2022, 13:20
Updated 11/08/2022, 14:11
© Reuters.  $7.5 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones jumped by more than 500 points on Wednesday following inflation data for July. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

Sonim Technologies

  • The Trade: Sonim Technologies, Inc. (NASDAQ: SONM) 10% owner AJP Holding Company LLC bought a total of 5,534,881 shares at an average price of $0.84. To acquire these shares, it cost around $4.65 million.
  • What’s Happening: The company, last month, announced the launch of its XP5plus on AT&T.
  • What Sonim Technologies Does: Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles.
  • The Trade: BitNile Holdings, Inc. (NYSE: NILE) Executive Chairman Milton C. Ault III acquired a total of 1,200,000 shares at an average price of $0.33. The insider spent around $399.96 thousand to buy those shares.
  • What’s Happening: Bitnile Holdings reported a 9.96% stake in HTG Molecular Diagnostics as of July 26 in a 13D Filing.
  • What BitNile Does: BitNile Holdings Inc is a diversified holding company owning subsidiaries engaged in commercial and defence solutions, commercial lending, and data centre operations in North America, Europe, the Middle East, and internationally.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Don’t forget to check out our premarket coverage here .

Astra Space

  • The Trade: Astra Space, Inc. (NASDAQ: ASTR) Director Michael Lehman acquired a total of 100,000 shares at an average price of $1.34. To acquire these shares, it cost around $134.26 thousand.
  • What’s Happening: Astra Space recently announced it will pause additional flights for the remainder of 2022 and said commercial launches in 2023 are dependent on the success of the company's test flights.
  • What Astra Space Does: Astra Space Inc is a technology company that provides space services, including satellite launch services and other space services, based on a proprietary, vertically integrated technology platform.
  • The Trade: Poseida Therapeutics, Inc. (NASDAQ: PSTX) 10% owner Malin Life Sciences Holdings Ltd acquired a total of 2,150,000 shares at an average price of $3.50. The insider spent $7.53 million to buy those shares.
  • What’s Happening: Poseida Therapeutics recently priced a 20 million share common stock offering at $3.50 per share.
  • What Poseida Therapeutics Does: Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.